A Bayesian Approach to the Design of Phase II Clinical Trials

DOI10.2307/2531594zbMath0715.62243OpenAlexW2329151889WikidataQ52553011 ScholiaQ52553011MaRDI QIDQ3201545

R. Sylvester

Publication date: 1988

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2531594

zbMATH Keywords

decision theoryhypothesis testrisk functionsample sizesmedicinedrug screeningdesign of Phase II clinical trials

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian problems; characterization of Bayes procedures (62C10)

Related Items (4)

Determination of the optimal sample size for a clinical trial accounting for the population size ⋮ Bayesian Optimal Design for Phase II Screening Trials ⋮ Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes ⋮ MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION

This page was built for publication: A Bayesian Approach to the Design of Phase II Clinical Trials